Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The last 3 or 4 stone tablets broke, waiting for a new stone to give a new time.
Stock closed at .087 today, though someone placed two $9.20 bids for 100 shares each just at the end to make it appear to close at .092. The only shares in the last hour before closing above .09 were those around 100 to 500 shares, just a few trades to try to make it hold up by an investor or two. Most all shares were trading below .089 in the last hour. Still we took another 4% drop.
If you see no news by opening, then expect another drop.
Now a change on your look here. Thought you said you were all in here and knew they were set to run up. Seems you changed your mind at the last moment.
Thanks, so it was just a play then.
If Rooney made that comment, then he is in a world of hurt.
He just gave out insider information if what you stated is true.
When they release the quarter news, if there is an inked partnership during this quarter, then they will have to report it to the stockholders in the filing. Then we can see if they are being honest in one happening with a $25B NYSE company.
You can be sure that the report will be looked at quickly by those in the market following this. If it is not seen, then expect a drop, or a run if it is there.
We hit .088 I see. Time for me to turn off the lights and hope for that news to come out soon.
With an hour left in the day, we may just see .082
It varies depending on when I bought into it. I did not buy it all at one time.
wallymac, I agree they have potential, they have the right product, but the lack of respect they are showing their stockholders and the way they present information is causing them to take a beating as we see how the market and stockholders are treating them. I still have my 220+K shares, not selling them at all, even if they go to a 0. I have just lost patience with them. Last Friday was the straw that broke the back.
Sorry for all the complaining. Maybe I shouid come back in August.
Short walk down almost every day. I would keep expecting a 4%-5% cut each day as we have been seeing for some time now. We may even end up in the .088 range today, which I am expecting .08 by end of week with continuing lack of news. At least my other penny stock has news out almost every other day if not every day. I am surprised it is so hard for Positron to make an effort at it. All just my opinion on how I see the market showing their concerns here.
wallymac, You just stated it yourself in your response of two weeks. That was to have been last Friday for the release.
As I said people look at the numbers in timeframes, not the extra words as we have all seen in the prior periods. People are very visual so they visualize a calendar date.
I will give you a few days, (Saturday, Sunday, Monday) already been 3 days past . Hopefully today the information will come out on day +4 if you want to give him that much time to be considered faithful. This would be 2-1/2 weeks, and we know once 3 weeks goes by then it is way late again.
Let's hope that they get their acts together before any of them lose their ratings and take each other down more.
You did not state Covidien by name, but since you and this board are saying it is and your wording back there, it appears that way.
I just did not read it that way in how Ronney's comment looked to me. I have no idea if he follows this board to make such a comment. I took his comment as it is a company the world in general knows, such as GE, McDonalds, Pepsi, etc. Something that is easily recognized is all. It could be Covidien, it seems to be Covidien, but I can not say 100% in how he worded his comment.
You may not care if this goes down in the short term, depending on what short term means to you, 1 month, 6 months, 6 years. This stock was highter 2 years ago based on the OS, sitting at .11 with much fewer OS. We have major dilution today.
Some I feel, like myself, expected that the company is trustworthy and when they come out stating it will be happening 3 times already and each time it does not happen, and no follow up on why it did not come out, this stock takes another beating as we have been seeing since April. Explains why people are happy to see it fall for shorting.
Friday was the last time we expected to hear on the partnership, 3rd time is a major strike in my mind. And I think the market, investors and stockholders will show their frustration again as we have seen today and through this week if they keep holding off on their word of revealing.
Can you post that email and highlight the area where he says we know it is Covidien, at least I take it that is what you are saying.
I hope your spell cast comes out any minute now. Been waiting over 2 months to hear it. Taken almost a 50% loss believing and expecting management to follow through on their words. Each time the next announcement period passes, the frustration and lack of trust grows stronger, as well as the price drops further with market's frustration. Hoping they can make up in the next hour what did not happen last Friday. Being 220+K deep into this, I have a pretty good right to my feelings on them for lack of any follow-through on their words.
Think about the 2008 news that was reported here over the weekend. They were already sitting at $0.11 per share, and had a lot less Outstanding Shares back then.
Maybe something to look into.
What do you mean by 'Come out?'
BMR released the news article from Positron that one would be happening, but it never came out as anything official from them in at Marketsite or the subsequent timeframes Rooney mentioned. Each time taking a hit for failing to deliver.
I take it the lack of news for last Friday as anticipated is being reflected in this morning's action. If I remember right, last week there were over 1M being bought up in the first half hour expecting news. Let's hope they come out this morning. Just my opinion folks, and I know it may be different than how some may look at it.
More from 2008: POSC At .11 Up 100%.Since.Profile.Launch
http://stockreads.com/Stock-Newsletter.aspx?id=301
POSC At .11 Up 100% Since Profile Launch
6/20/2008 10:23 AM Penny Stocks by: Shazam Stocks
Positron Corp.
(OTCBB: POSC) View Profile Press Release Source: Positron Corporation Positron Corporation Receives Positive Feedback at Society of Nuclear Medicine Meeting Thursday June 19, 12:05 pm ET HOUSTON--(BUSINESS WIRE)--Positron Corporation (OTC: POSC - News) (the ?Company?) recently displayed their molecular imaging and automated radioisotope dose drawing systems at the Society of Nuclear Medicine Meeting in New Orleans, Louisiana. Approximately 3,900 attendees and over 180 exhibiting companies attended the meeting. The Society of Nuclear Medicine meeting is the world`s largest event focused exclusively on the latest developments in molecular imaging technology and nuclear medicine based products and services.
"We received a great deal of positive feedback on our recent acquisition of Dose Shield Corporation and the integration of our product portfolio under one brand allowing for the sale of a turn-key solution encompassing imaging system, dose dispensing system, radiopharmaceutical and disease management software," stated Joe Oliverio, President of Positron. ?Of particular note,? continued Mr. Oliverio, ?potential customers were pleasantly surprised to hear of our upcoming market release of an economically priced PET system that is design optimized for cardiology applications We are not aware of any other company selling a PET only into the USA market. We look forward to meeting the demand for a more economical product in cardiac PET, and our goal is to be delivering devices immediately after receiving our FDA 510k approval.? About Positron Corporation Positron Corporation is a growing healthcare company offering cardiac molecular imaging solutions that will transform the delivery of healthcare through radiopharmaceutical development, advancing imaging technology and by introducing unique disease management applications into the market. Positron Corporation designs, manufactures and sells SPECT, PET and automated dose delivery devices in to the Nuclear Medicine market. Additional information may be found at http://www.positron.com/.
Forward-Looking Statements This press release contains forward-looking statements that reflect the Company`s current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Positron Corporation are ?forward-looking statements? within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied including the success of the Company`s research and development efforts, the availability of adequate financing and other uncertainties described in the ?Management?s Discussion and Analysis? section of the Company?s Form 10-KSB and other reports and filings with the Securities and Exchange Commission.
For any additional information contact Positron?s President, Joe Oliverio at (281) 492-7100.
Contact:
Positron Joe Oliverio at (281) 492-7100 -------------------------------------------------------------------------------- Overview Positron Medical Systems (the "Company") is a growing healthcare company offering cardiac molecular imaging solutions that will transform the delivery of healthcare through radiopharmaceutical development, advancing medical imaging technology and by introducing unique disease management applications into the market. The company?s molecular imaging systems incorporate patented and proprietary software and hardware technology for the diagnosis and treatment of patients with heart disease. Through the recent acquisition of Dose Shield, Inc., Positron Medical Systems will now be able to offer a unique combination of low cost medical imaging technology, affordable radiopharmaceutical solutions and disease specific programs / software differentiating themselves from all other medical device manufacturers.
A substantial change in the market landscape is occurring. These changes involve product mix, regulatory requirements, and the expiration of patents on lucrative protected radiopharmaceutical products.
Positron?s software, equipment and drugs are all focused on cardiology, the largest segment of Nuclear Medicine.
The reoccurring revenue generated each year by the US nuclear cardiology market for radiopharmaceuticals is in excess of $1.2 Billion. Five year revenue potential by adding radiopharmaceuticals to the equipment sale are $1.7M / SPECT customer and $2.5M / PET customer. Positron expects to sell greater than 200 SPECT and 300 PET devices. The market for Nuclear Pharm-Assist® sold to existing radiopharmacies and hospitals as well as selling the Cardio-Assist into the cardiologist practice approaches 10,000 targets. Positron will focus on further expanding its ability to compete with other imaging device vendors as well as increase its ability to generate reoccurring revenue at higher margins.
Nuclear Pharm-Assist® by NukeMed, Inc. offers unique delivery methods by creating a first time virtual pharmacy in-house for customers. As part of Positron expanding into providing pharmaceuticals with the Nuclear Pharm-Assist® automated dispensing device, the company will leverage its knowledge of the FDA and begin to manufacture the primary radioactive drugs prescribed in nuclear cardiology such as Tc-99m generators, Rb-82 generators and Thallium 201.
Positron Medical is addressing the needs of the cardiac molecular imaging market. The Company`s joint venture Neusoft Positron Medical Systems Co. Ltd. based in Shenyang, People`s Republic of China provides Positron Medical a cardiac Positron Emission Tomography (PET) imaging system that can be priced below all competitors. . Positron Medical Systems also offers a competitively priced Single Photon Emission Computed Tomograhy (SPECT) imaging system. The PET and SPECT imaging devices complement each other and positions Positron Medical Systems to capture reoccurring revenue by selling generic radiopharmaceuticals that are the result of recent patent expirations of two key PET and SPECT radiopharmaceuticals. Positron Medical has acquired unique expertise and technology through their acquisition of Dose Shield, Inc. to directly expedite the company?s entry into the radiopharmaceutical market. Combining the sale of these radiopharmaceuticals to the customer with Positron Medical proprietary imaging technologies greatly expands the Company?s ability to capture a significant amount of recurring revenue per sale that greatly exceeds an equipment sale by itself.
Positron is currently developing a coronary disease reversal and prevention online management & solution program. This was made possible by Positron?s agreement with Dr. K. Lance Gould and the University of Texas for exclusive rights to Dr. Gould?s heart disease reversal diet and comprehensive practice management, patient centric program. The Company believes that its online coronary disease reversal and prevention product will provide a solution for patients, insurers, self insured corporations and thousands of community hospitals looking to differentiate their services, save cost and reducing outward migration of patients to the larger hospitals.
Investment Highlights:
Early stage of new marketplace created by a market dynamic shift Only full solutions provider of PET/SPECT/Pharma/Disease management/Solid state Undervalued market capitalization Clinically experienced management with proven market success Opportunity through NukeMed to capitalize on radiopharmaceutical business and off patent tracers First time in nuclear cardiology history that the most prescribed radiopharmaceuticals are going generic JV with Neusoft for Chinese manufacturing and development Contact Information Positron Corp.
1304 Langham Creek Dr #300 Houston, TX 77084 Phone: (281) 492-7100 Toll Free: (800) 766-2984 Fax: (281) 492-2961 Email: contact@positron.com Website: www.positron.com -------------------------------------------------------------------------------- Profiles is a special advertising section presented by Shazamstocks.com. All material listed within http://shazamstocks.com/profiles/index.php ("Profiles") was based upon information supplied by the company or from other sources believed to be reliable. The information contained Profiles is not guaranteed by Profiles to be accurate and should not considered to be all-inclusive. The companies discussed on Profiles except for those companies that appear on the URL http://shazamstocks.com/profiles/index.php have not approved the statements made herein. Any discussions and pages contain forward looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward - looking statements or announcements discussed on Profiles. We have been compensated by positron 1.5 million rule 144 restricted shares for publication of this profile. All material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Profiles is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst, or underwriter. Companies profiled at URL http://shazamstocks.com/profiles/index.php are ineligiable for recommendations on URL http://www.shazamstocks.com for 90 days following final disposition of any compensation.
-------------------------------------------------------------------------------- This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies` annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Shazamstocks Inc undertakes no obligation to update such statements.
CONTACT: Ken Weiner Tel: +1 561 793 2665 e-mail: editor@shazamstocks.com Shazamstocks Inc | 125 South state Road 7 Suite 104-221 | Palm Beach | FL | 33411
I think the market was waiting to hear of news today for the low volume we experience compared to the days prior in loading up. Will be interesting to see how Monday goes.
My order filled for 950@.096 at 10:51.
I do not see the 950 share posted at that time, so I can only guess it was done within the 5000 shares traded at that time.
Yes very low volume. I think most are waiting to see if anything is announced today. Hopefully by 1 PM at the latest I would expect, but a lot of news comes out around 10:30 AM I have noticed from other companies.
I placed an order for 950 shares @ .096 to see if anything happens.
Buy_to_Sell Volume 24,600_to_192,333
So that was you. I see .101/.103 on prices.
I first thought it was a MM to get something out there.
I also thought maybe this was going to run due to no one selling at these prices.
No trading 5 minutes into the day.
If a deal has been inked then they have to file it and report it to their shareholders.
On the question, can we add in...
and ask if this is the $25B NYSE company or if the $25 NYSE company a new partnership
How does everyone read into what Rooney said here?
Those type of phone numbers are when someone calls from a computer.
OK, Thanks. I thought I was wrong.
I am trying to get the facts straight in me asking.
Need some help in knowing if I am correct here. I am probably reading it wrong.
1) Apr 30th or earlier: PR release stating announcement will be on MarketSite Day.
2) May 5th: Announcement changed to 'two weeks to a month or so'.
3) Jun 11th: Email posted reflecting announcement as 'I hope in two weeks'.
4) Jun 24th: Email posted reflecting to 'Please look month to month' for announcement.
Am I reading all of this history correctly here and in how the email appears today?
Understands your private message comments.
I have heard that news for a lil while now. Been waiting to hear what they decide to do. I hope they decide soon.
I am surprised, I have been gone for several hours and the bid/ask has not changed at all.
Oh I think it would go higher than .25. I just hope that we can get back to .25 before that news comes out, as I think that will help us even more on the price going up much much highter is all.
I thought they had to report it publicly so they are not hiding anything from their stockholders and the market?
barber, I understand, I just hope Rooney follows through with his comments about this week, or at least comes out with a comment so others do not get upset as we have seen before. And at this point I would expect any paperwork after 3 months or so would be enough time to get it tied up. Just my opinion.
dblue, chill. Not sure what caused that reaction. I was just saying I hope it can get back to .25.
I worry if this can not make it back to .25, then we will lose seeing a larger run up as we were expeccting to see.
Surprisingly it did not have much of an impact at all I am seeing in level II now. I thought we were going to be seeing a run based on the large volume in the first minute and rise in price after they took out the stops.
Update two minutes later. Another push back down on volume to get it lower. Wonder how today will turn out.